Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging strategies to target RAS signaling in human cancer therapy
Kun Chen, Yalei Zhang, Ling Qian, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 158

Showing 26-50 of 158 citing articles:

A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001)
Huajun Chen, Hai‐Yan Tu, Yanping Hu, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutic
Manish Kumar
Authorea (Authorea) (2025)
Open Access
Rat Sarcoma Virus Family Genes in Acute Myeloid Leukemia: Pathogenetic and Clinical Implications
Shaimaa Khattab, Adriatik Berisha, Natalia Baran, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 202-202
Open Access
Resistance to FLT3 inhibitors involves different molecular mechanisms and reduces new DNA synthesis
Jingmei Yang, Ran Friedman
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101894-101894
Closed Access
First molecules to reactivate RASG12V GTPase activity
Aneta Włodarczyk, Cezary Tręda, Marcin Pacholczyk, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Dynamic and Biphasic Regulation of Cell Migration by Ras
Yiyan Lin, Eleana Parajón, Qinling Yuan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Precision medicine in colorectal cancer: genomics profiling and targeted treatment
Adi Muradi Muhar, Adrian Joshua Velaro, Arya Tjipta Prananda, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
A multi-objective artificial bee colony approach for identifying cancer driver pathways
Fernando M. Rodríguez-Bejarano, Miguel A. Vega‐Rodríguez, Sergio Santander‐Jiménez
Expert Systems with Applications (2025) Vol. 275, pp. 127071-127071
Closed Access
Oncogenic RAS induces a distinctive form of non-canonical autophagy mediated by the P38-ULK1-PI4KB axis
Xiaojuan Wang, Shulin Li, Shiyin Lin, et al.
Cell Research (2025)
Open Access
miR-660: A novel regulator in human cancer pathogenesis and therapeutic implications
Zehua Wang, Xinming Su, Zhiqing Zhan, et al.
Gene (2025), pp. 149434-149434
Closed Access
In Silico Identification of Putative Allosteric Pockets and Inhibitors for the KRASG13D-SOS1 Complex in Cancer Therapy
Zehra Sarica, Özge Kürkçüoğlu, Fethiye Aylin Sungur
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3293-3293
Open Access
Myricetin induces cell cycle arrest and suppresses tumorigenesis in bladder cancer through the interaction of EGFR-Ras and Fas signaling pathways
Xiumin Xu, Hongtao Yu, Yuesheng Wang, et al.
Research Square (Research Square) (2025)
Closed Access
Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives
Svetlana N. Aleksakhina, Evgeny N. Imyanitov
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 10931-10931
Open Access | Times Cited: 31
Blockade of mutant RAS oncogenic signaling with a special emphasis on KRAS
Robert Roskoski
Pharmacological Research (2021) Vol. 172, pp. 105806-105806
Closed Access | Times Cited: 27
Role of RAS signaling in ovarian cancer
Lubna Therachiyil, Anjana Anand, Abdullah Azmi, et al.
F1000Research (2022) Vol. 11, pp. 1253-1253
Open Access | Times Cited: 21
Noncoding RNAs in the Glycolysis of Ovarian Cancer
Chunmei Zhang, Ning Liu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers
Elona Cekani, Samantha Epistolio, Giulia Dazio, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4103-4103
Open Access | Times Cited: 19
RASGRP2 is a potential immune-related biomarker and regulates mitochondrial-dependent apoptosis in lung adenocarcinoma
Yongting Liu, Yanhong Ouyang, Ziyang Feng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen
Katharine M. Wright, Sarah R. DiNapoli, Michelle S. Miller, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Biological functions and research progress of eIF4E
Xiaocong Chen, Yang An, Mengsi Tan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Serum response factor promoting axonal regeneration by activating the Ras–Raf‐Cofilin signaling pathway after the spinal cord injury
Limin Gao, Chen Zhang, Yonglin Zhu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 4
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside
Elif Çakan, Olivia D. Lara, Anna Szymanowska, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2940-2940
Open Access | Times Cited: 4
RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms
Xiaojuan Yang, Hong Wu
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance
Enrique Rozengurt, Guido Eibl
Cancers (2021) Vol. 13, Iss. 20, pp. 5126-5126
Open Access | Times Cited: 23
Worldwide Prevalence and Clinical Characteristics of RAS Mutations in Head and Neck Cancer: A Systematic Review and Meta-Analysis
Ofra Novoplansky, Sankar Jagadeeshan, Ohad Regev, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17

Scroll to top